Soligenix, Inc. , a late-stage biopharmaceutical company, announced today the publication of an article online in Vaccine. Ã The article describes the systematic identification of neutralizing and non-neutralizing B-cell epitopes on ricin toxin's enzymatic A subunit .
More...